Figure 2. Immunomodulatory Treatments Received during Hospitalization and Indicators of Clinical Severity.

Panel A shows the extent of variability in immunomodulatory treatment that patients with MIS-C received during hospitalization. Panel B shows the distribution of patients whose hospital course included indicators of clinical severity of illness, according to immunomodulatory treatments received during hospitalization. Left ventricular ejection fraction (LVEF) was measured by means of echocardiography. ICU denotes intensive care unit.